5 5 SOCIAL: Global Health Equity Unit 2021 2020 2019 Number of products on the WHO List of Prequalified Medicinal Products and Vaccines as part of its Prequalification of Medicines Programme and Prequalification of Vaccine Programme # 8 6 6 Patients provided access to MDR-TB treatment # 1 3 7, 9 2 7 133,565 105,365 Cumulative doses of VERMOX (mebendazole) donated since the start of the initiative through the WHO and private donations billions 2.0 1.8 1.6 Johnson & Johnson products provided to communities impacted by natural disasters million $ $6.69 $1.86 $36.70 Total products and cash contributed globally million $ $2,738 $2,567 $1,806 ENVIRONMENT: Environmental Health (continued) Unit 2021 2020 2019 GHG emissions intensity (Scope 1 + Scope 2) by revenue MT CO 2 e / million $ 8 9 12 Percentage absolute reduction in GHG emissions – Scope 3 (upstream) vs. 2016 baseline ** % 1% increase Not reported Not reported Total water use in areas of high or extremely high baseline water stress million m 3 4.45 Not reported Not reported Total waste diverted from disposal MT 166,645 158,309 161,530 Total waste directed to disposal MT 2 8 ,1 9 2 25,250 33,744 Manufacturing and R&D sites certified to ISO 14001 % 89% 96% 97% Number of LEED-certified Johnson & Johnson buildings # 67 60 54 GOVERNANCE: Accountability & Innovation Unit 2021 2020 2019 Total tax contribution billion $ $ 1 3.1 $12.0 Not reported R&D investment million $ $14,714 $12,159 $11,355 Women in Board composition % 35.7% 35.7% 28.6% Ethnic/racial diversity in Board composition % 21.4% 21.4% + 21.4% Percentage of active employees who completed biennial Code of Business Conduct training % 98% Not reported 97% Percentage of sales and marketing employees who completed healthcare compliance training % 97% 96% 95% Employees covered by collective bargaining agreements % 30% 23% 20% Total Global Impact Spend ** billion $ $5.22 Not reported Not reported FDA inspections that resulted in zero observations % 56% 80% 76% Percent of invited suppliers participated in CDP Supply Chain Climate program % 82% 80% 84% Product recall rate by business segment Pharmaceutical % 0% 0% 0.002% MedTech % 0.059% 0.034% 0.041% Consumer Health % 0% 0% 0.091% SOCIAL: Our Employees Unit 2021 2020 2019 Total employees # 144,315 136,360 137,701 Total number of new hires # 22,543 13,594 21,948 Gender representation of global employees % women 49% 48.1% 47.8% Women in management positions ** % 48.0% 46.4% 45.8% Ethnic/racial diversity in management positions in the U.S. ** % 34% Not reported Not reported Managers and above moved across functions, country or business segment lines % 45.8% 44.6% 42.6% Overall voluntary turnover % 8% 5% 8% Spend on employee learning and development million $ $150 $108 $98 Total Recordable Injury Rate % 0.30 0.24 0.31 Lost Workday Case rate % 0.06 0.05 0.07 Number of fatalities # 0 0 0 ESG Data Summary * * For full details of our performance and notes on all data points, see our ESG Performance Data. ** Represents progress against a Health for Humanity 2025 Goal. For more information, see Health for Humanity 2025 Goals Scorecard. ENVIRONMENT: Environmental Health Unit 2021 2020 2019 Total energy use TJ 11,947 11,954 12,702 Energy intensity ratio TJ/billion $ 127 145 155 Electricity generated from renewable sources ** % 52% 54% 30% Scope 1 + Scope 2 GHG emissions, total MT CO 2 e 764,760 747,166 968,830 Percentage decrease in GHG emissions intensity (Scope 1 + Scope 2) by revenue compared to 2016 baseline MT CO 2 e / million $ 50% 44% 27%